Preclinical, Translational and Clinical-Stage Laboratories
Who We Are
MD Biosciences is a global industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. With AAALAC-accredited, GLP-compliant, CLIA facilities, we offer services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism and pain. In order to provide the best quality offerings with expertise and optimize research in each specialized area, we operate 4 separate divisions: MD Biosciences Inflammation/Immunology Services, MD Biosciences Neurology Discovery Services, MD Biosciences Histopathology Services and MD Bioproducts.
What We Do
In-depth understanding of immunology and inflammatory processes are a cornerstone of MD Biosciences. Offering both in vitro and in vivo models, we can support your program at early stage screening, test item pharmacology and efficacy assessment, as well as the later translational stages. Models are further supported by comprehensive ex vivo biomarker analysis, allowing for a multifaceted approach to best understand your compounds mechanism of action. Methods include flow cytometry, picogram level proteomic analytics, genomic assessments such as qPCR, automated Western Blot and multiplexed protein analysis.
Advanced capabilities for in-depth assessment of tissue parameters with support at each stage in the histology workflow including digital image analysis. From sample preparation through to staining and assessment by our pathologists, we ensure the highest quality of data production to progress your programs forward. We have developed histological assays, IHC protocols, custom ISH probes and unique scoring methods for numerous project types with standard and customized read outs, and are always willing to discuss new assessments to meet client needs.
With a multifaceted approach to assessment of neurological diseases, specializations include pain-related work, neurodegenerative diseases including Parkinson's, neuro-inflammatory diseases such as Multiple Sclerosis (MS), and capabilities in stroke and cerebral ischemia. Preclinical models are complimented by in house histology, biomarker analysis and electrophysiology capabilities. Finally, our unique porcine models share a high degree of similarity to humans, thus offering greater clinical efficacy that serve to augment and accelerate your program towards their next objectives and milestones.
Established in 1991, MD Biosciences offers services and products including antibodies, reagents and assays, for inflammatory and autoimmune diseases, neurology, oncology, pain, and metabolism. We offer pre-clinical, translational and clinical-phase contract research for the development of pharmaceutical and diagnostic assets. We collaborate with pharmaceutical, biotech, academic and government communities to provide you with the tools needed to optimize your research process enabling you to reach your objectives faster.
What We Bring
25+ years experience working with biotechnology, pharma, medical, government and academic communities
High level of flexibility
Transparent sharing of information
Each project is a team-oriented research effort
Host frequent discussions with Sponsors to determine ultimate study objectives, adapt to new information as it is generated and provide insight where possible.
"MD Biosciences, providing elegant solutions with expert execution for over 25 years"
3510 Hopkins Place North
Oakdale, MN 55128
Tel: (651) 641 1770
Toll Free: 888-876-3246
Fax: (651) 641 1773
Cambridge Office: 617 764 6555 Fax: (651) 641 1773 Email
MD Biosciences Innovalora Ltd
Weizmann Science Park
3 Sapir Street
Nes Ziona, Israel Tel: +972 (8) 939 6884 Email
MD Biosciences GmbH
8132 Egg b. Zürich Switzerland
Tel: +41-44 986 2628
Fax: +41-44 986 2630